EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, BCRX: Biocryst Pharma Inc

04 Nov 25 15:59
LAST:

6.765

CHANGE:
 0.10		OPEN:
6.700		HIGH:
6.895		ASK:
4.360		VOLUME:
7.16M
CHG(%):
1.46		PREV:
6.860		LOW:
6.510		BID:
10.120		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 256.7006.8906.5106.7608.82M
03 Nov 257.1507.2606.7506.8609.82M
31 Oct 257.2807.4707.1807.3205.73M
30 Oct 257.3107.4307.2107.2504.88M
29 Oct 257.1807.3757.1707.3105.08M
28 Oct 257.3107.3307.1707.2406.04M
27 Oct 257.2607.3407.1727.3104.22M
24 Oct 257.2307.3407.1507.2003.9M
23 Oct 257.0507.2406.9707.1903.81M
22 Oct 256.9907.1606.8707.0806.21M

COMPANY PROFILE

Name:Biocryst Pharma Inc
About:BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Sector:Healthcare
Address:4505 Emperor Boulevard, Durham, NC, United States, 27703
Website:https://www.biocryst.com
CUSIP:09058V103
CIK:0000882796
ISIN:US09058V1035
FIGI:BBG000BLYWX6
LEI:549300Z0INP1Z5NP6J59

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-15.95 
Forward P/E:-183.00 
PEG Ratio:0.12 
Price to Sales:2.76 
Price to Book:-3.41 
Profit Margin:-0.06 
Operating Margin:0.18 
Return on Assets:0.07 
Return on Equity:0.19 
EPS Ratio:-0.18 
Revenue:557.51M 
EBITDA:13.45M 
Shares:209.92M 
Market Cap:1.42B 

TECHNICAL INDICATORS

MA5:7.105.0%
MA10:7.155.7%
MA20:7.044.1%
MA50:7.5311.3%
MA100:8.1720.8%
MA200:8.4625.1%
STO14:15.48 
RSI14:48.52
WPR14:-81.16 
MTM14:0.04
ROC14:0.01 
ATR:0.27 
Week High:7.4710.4%
Week Low:6.513.9%
Month High:7.4710.4%
Month Low:6.0025.1%
Year High:11.3167.2%
Year Low:6.0012.8%
Volatility:3.14